We corroborated this hypothesis in pre-clinical in vivo models in which the inhibition of CCR7 by anti-CCR7 antibodies abrogated infiltration of CCR7-expressing MCL cell lines into LN, spleen, lung, or CNS, all of them tissues in which CCR7 ligands are found (21). This evidence concerns the gene CCR7 and mantle cell lymphoma.